NOVARTIS PHARMACEUTICALS CORPORATION

Lobbying Spend

—

Filings

Firms Hired

Active Period

2009–2016

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	5	1
2010	—	4	1
2009	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BOCKORNY GROUP, INC.	—	33

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	31
SENATE	26
U.S. Trade Representative (USTR)	24
Commerce, Dept of (DOC)	8

Most frequently reported lobbying issues

Issue Code	Description	Reports
Trade (domestic/foreign)	Trade (domestic/foreign)	31
Health Issues	Health Issues	7

NOVARTIS PHARMACEUTICALS CORPORATION — Lobbying Disclosure | Poliscope